Get complete Patent Opposition Report for Gallafent

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Gallafent

Explore patent oppositions filed by Gallafent against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP1731152Sustained Analgesia Achieved With Transdermal Delivery Of BuprenorphineEURO CELTIQUEJan 24, 2014